Most of the patients presenting GluA3 antibodies in the Borroni et al. (2017) study revealed a presenile-onset, a behavioral variant of frontotemporal dementia, and their MRIs revealed atrophy in bitemporal regions. The gene discussed is GRIA3; the disease is frontotemporal dementia.